Number of SEER-MHOS Respondents (Age 65+) by First Cancer Site, 1998-2014

First Cancer (#) Number of linked Patients with One or More survey
(Group A)
More than one survey*
(Subset of Group A)
Survey before Cancer Diagnosis
(Group B)
Survey both before and after Cancer Diagnosis**
(Subset of Group B)
Survey after Cancer Diagnosis
(Group C)
N % N % N % N %
Prostate (28010)  28,730 13,124 (45.68) 8,748 (30.45) 1,996 (6.95) 21,975 (76.49)
Breast (26000) 24,793 11,922 (48.09) 7,313 (29.50) 1,556 (6.28) 19,033 (76.77)
Colorectal (21041-21052) 15,833 7,207 (45.52) 6,336 (40.02) 1,023 (6.46) 10,518 (66.43)
Lung and bronchus (22030) 12,103 4,608 (38.07) 9,241 (76.35) 691 (5.71) 3,549 (29.32)
Ovary (27040) 1,509 673 (44.60) 758 (50.23) 79 (5.24) 830 (55.00)
Uterus(27020, 27030) 4,583 2,192 (47.83) 1,153 (25.16) 228 (4.97) 3,658 (79.82)
Cervix (27010) 1,791 802 (44.78) 155 (8.65) 16 (0.89) 1,652 (92.24)
Bladder (29010) 7,157 3,191 (44.59) 3,145 (43.94) 522 (7.29) 4,534 (63.35)
Melanomas -- skin (25010) 7,182 3,522 (49.04) 2,837 (39.50) 520 (7.24) 4,852 (67.56)
Head and Neck (20010-20100,22010,22020) 3,483 1,536 (44.10) 1,377 (39.53) 209 (6.00) 2,315 (66.47)
Kidney and Renal pelvis (29020) 3,025 1,366 (45.16) 1,460 (48.26) 247 (8.17) 1,812 (59.90)
Non-Hodgkin's lymphomas -- nodal and extranodal (33041,33042) 4,351 1,950 (44.82) 2,313 (53.16) 305 (7.01) 2,342 (53.83)
Stomach (21020) 1,644 637 (38.75) 1,128 (68.61) 86 (5.23) 602 (36.62)
Pancreas (21100) 2,143 795 (37.10) 1,949 (90.95) 79 (3.69) 273 (12.74)

# 5-Digit site recode.External Web Site Policy

* At least one survey must be two years after first survey.

** Number of individuals with a survey before their first cancer diagnosis and also a survey after their first cancer diagnosis.

Note: The denominator for the percentages that appear in columns 3 through 6 is the Number of linked patients with one or more survey by cancer site (column 2).

The groups in columns 4 through 6 are not mutually exclusive, therefore, the percentages do not sum to 100.